Rapid Molecular Detection of Rifampicin Resistance Facilitates Early Diagnosis and Treatment of Multi-Drug Resistant Tuberculosis: Case Control Study.

MLA

O’Riordan, Philly, et al. “Rapid Molecular Detection of Rifampicin Resistance Facilitates Early Diagnosis and Treatment of Multi-Drug Resistant Tuberculosis: Case Control Study.” PLoS ONE, vol. 3, no. 9, Sept. 2008, pp. 1–7. EBSCOhost, https://doi.org/10.1371/journal.pone.0003173.

APA

O’Riordan, P., Schwab, U., Logan, S., Cooke, G., Wilkinson, R. J., Davidson, R. N., Bassett, P., Wall, R., Pasvol, G., & Flanagan, K. L. (2008). Rapid Molecular Detection of Rifampicin Resistance Facilitates Early Diagnosis and Treatment of Multi-Drug Resistant Tuberculosis: Case Control Study. PLoS ONE, 3(9), 1–7. https://doi.org/10.1371/journal.pone.0003173

Chicago

O’Riordan, Philly, Uli Schwab, Sarah Logan, Graham Cooke, Robert J. Wilkinson, Robert N. Davidson, Paul Bassett, Robert Wall, Geoffrey Pasvol, and Katie L. Flanagan. 2008. “Rapid Molecular Detection of Rifampicin Resistance Facilitates Early Diagnosis and Treatment of Multi-Drug Resistant Tuberculosis: Case Control Study.” PLoS ONE 3 (9): 1–7. doi:10.1371/journal.pone.0003173.